Paradromics Joins the Race in Brain-Computer Interface Technology with Successful Human Implant

Paradromics Achieves Milestone with Human Brain Implant

In a significant advancement in the field of brain-computer interfaces (BCIs), Texas-based company Paradromics has successfully implanted its Connexus BCI in a human patient. The procedure, conducted during epilepsy resection surgery at the University of Michigan, marks a crucial step forward in the competitive landscape of neural technology 1

1

The Connexus BCI: A Technological Marvel

Source: Inc.

The Connexus BCI, smaller than a dime, utilizes artificial intelligence to translate brain signals at the neuron level into physical movement and communication. This breakthrough technology aims to assist individuals with severe motor impairments resulting from conditions such as ALS, strokes, or spinal cord injuries 1

1

Paradromics CEO Matt Angle, who co-founded the company a decade ago, stated, "We are now a clinical-stage company," highlighting the significance of this achievement 1

1

Clinical Trials and Future Plans

The recent human trial follows three years of preclinical trials in sheep. According to Paradromics, the procedure "demonstrated Connexus can be safely implanted, record electrical brain signals, and be removed intact in less than 20 minutes, using surgical techniques familiar to neurosurgeons worldwide" 1

1

While this marks a crucial milestone, the device still requires further approval at the clinical level before commercialization. Paradromics has announced plans for "several" similar surgeries in 2025, indicating a commitment to advancing their technology 1

1

Related Stories

Chinese Brain Chip Project Accelerates Human Trials, Challenging Global Competitors

Precision Neuroscience Raises $102 Million, Challenging Neuralink in Brain-Computer Interface Race

Neuralink's Brain Chip Implanted in Second Human Patient

Neuralink's Second Brain Implant Patient Plays Video Games with Mind Control

The Competitive Landscape of BCI Technology

Paradromics' achievement places it in direct competition with other prominent players in the BCI field:

1. Neuralink: Elon Musk's company completed three BCI surgeries in 2024. Their first patient, despite initial challenges with electrode slippage, has become an enthusiastic proponent of the technology 2

   2

   .

2. Synchron: Backed by Bill Gates and Jeff Bezos, Synchron has been implanting its stent-like device since 2019. Recently, they partnered with Apple to explore enabling phone control through their implant 2

   2

   .

3. NeuCyber NeuroTech: This Chinese state-owned company plans to implant its brain chip in 13 people by the end of the year 1

   1

   .

4. Precision Neuroscience: Founded by former Neuralink employees, this company is also making strides in BCI technology 1

   1

   .

Technological Distinctions and Implications

Source: Quartz

A key differentiator among these companies lies in their approach to brain connectivity. Both Neuralink and Paradromics have developed BCIs that connect directly to brain tissue, which is considered crucial for high-quality, high-resolution signals, particularly beneficial for speech-related applications 1

1

As the field of BCI technology continues to advance, it holds the potential to revolutionize treatment for individuals with severe motor impairments and possibly lead to broader applications in human-AI interaction.